Ischemic Stroke with Positive Antiphospholipid Antibodies in Bloom Syndrome: A Case Report

Review Clinical Neurology

Antiphospholipid syndrome, antiphospholipid antibodies, and stroke

Prabal Mittal et al.

Summary: Antiphospholipid syndrome (APS) is a well-established cause of acute ischemic stroke (AIS) and transient ischemic attack (TIA). It has a wide spectrum of cerebrovascular lesions, including white matter hyperintensities, cortical atrophy, and infarcts, with clinically important neurocognitive sequalae. The diagnosis and management of APS-associated AIS/TIA require expert evaluation, and there are uncertainties regarding optimal antithrombotic therapy for secondary prevention.

INTERNATIONAL JOURNAL OF STROKE (2023)

添加到收藏夹

Article Hematology

Profile of antiphospholipid antibodies in HIV-infected and HIV-uninfected women with a history of thrombosis

Elise Schapkaitz et al.

Summary: This study found that the prevalence and expression of antiphospholipid antibodies (aPL) in HIV-infected women with a history of thrombosis were similar to HIV-uninfected women. However, baseline positivity of lupus anticoagulant (LAC) was significantly associated with an increased risk of thrombosis in HIV.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies

Antonio Cristiano et al.

Summary: This study examined the presence of anti-phospholipid antibodies in COVID-19 patients and found that some patients may have COVID-19-induced antiphospholipid antibody syndrome. The results revealed potential inflammatory statuses and thrombotic indicators.

CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Immunology

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove

Savino Sciascia et al.

Summary: The presence of antiphospholipid antibodies in COVID-19 patients may contribute to a pro-coagulant state, but differs from patients with overt APS. Therefore, caution is needed in interpreting and generalizing the role of aPL in the management of COVID-19 patients. Additional well-designed clinical studies are necessary before introducing aPL testing as routine in COVID-19 patients.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Case Report: Diabetes in Chinese Bloom Syndrome

Mingqun Deng et al.

Summary: Bloom syndrome (BS) is a rare autosomal recessive disorder, with only one reported case without diabetes in the Chinese population. This study presented the first case of BS with diabetes in China, identifying a new pathogenic variant in the BLM gene and highlighting BS as a rare cause of diabetes in the Chinese population.

FRONTIERS IN ENDOCRINOLOGY (2021)

添加到收藏夹

Review Rheumatology

Systematic review of case reports of antiphospholipid syndrome following infection

N. Abdel-Wahab et al.

LUPUS (2016)

添加到收藏夹

Review Dermatology

Dermatological manifestations of inherited cancer syndromes in children

A. Karalis et al.

BRITISH JOURNAL OF DERMATOLOGY (2011)

添加到收藏夹

Ischemic Stroke with Positive Antiphospholipid Antibodies in Bloom Syndrome: A Case Report

相关参考文献

Antiphospholipid syndrome, antiphospholipid antibodies, and stroke

Profile of antiphospholipid antibodies in HIV-infected and HIV-uninfected women with a history of thrombosis

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove

Case Report: Diabetes in Chinese Bloom Syndrome

Systematic review of case reports of antiphospholipid syndrome following infection

Dermatological manifestations of inherited cancer syndromes in children

导出引文

分享论文